N-desalkyludenafil

Metabolite details

Identifier

WQAFYWMRZOZKJD-UHFFFAOYSA-N

InChI Key

WQAFYWMRZOZKJD-UHFFFAOYSA-N

IUPAC name

3-(1-methyl-7-oxo-3-propyl-6H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-propoxybenzenesulonamide

Preferred name

N-desalkyludenafil

INN name

—

Synonym

—

ChEBI

CHEBI:168835

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Effect of L-carnitine administration on lipid and metabolite content in sheep infraspinatus muscle after tendon release
• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• Metabolomic Insights into the Browning of the Peel of Bagging ‘Rui Xue’ Apple Fruit
• Interaction between Cervical Microbiota and Host Gene Regulation in Caesarean Section Scar Diverticulum

Observed in differential profiles

• Control_16.6_months_vs_Treatment_16.6_months
• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• Non_Bagged_Fruits_vs_Bagged_Fruits_With_Browning
• Control_vs_CSD